|
|
|
 |
FDA Approval Activities for this Drug…
Altace (ramipril) Capsules, 1.25, 2.5, 5, and 10 mg, King NDA 19-901/S-035 7/10/02 7/15/02 Altace (ramipril) Capsules, 1.25, 2.5, 5, and 10 mg, King NDA 19-901/S-034 8/2/02 8/6/02 Altace (ramipril) Capsules,1.25, 2.5, 5, & 10 mg Hoechst Marion Roussel, NDA 19-901/S-025 12/16/98 3/13/00 Altace (ramipril) Capsules , 1.25, 2.5, 5, and 10 mg, King NDA 19-901/S-028 10/4/00 Altace Indication: Reduction in risk of myocardial infarction, stroke, and death from cardiovascular causes RAMIPRIL Capsule; 1.25MG ALTACE KING 019901 RAMIPRIL Capsule; 10MG ALTACE KING 019901 RAMIPRIL Capsule; 2.5MG ALTACE KING 019901 RAMIPRIL Capsule; 5MG ALTACE KING | Altace (ramipril) Capsules, King Pharma, Labeling Revision | Altace (ramipril) Capsules, King Pharmaceuticals, Labeling Revision | Ramipril Capsules, Roxane Labs, Tentative Approval | Ramipril Capsules, Sandoz Inc., Tentative Approval | Ramipril Capsules, Teva Pharma, Tentative Approval | Ramipril Capsules, Dr. Reddy’s Labs, Tentative Approval | Ramipril Capsules, Dr. Reddy’s Labs, Tentative Approval | Ramipril Capsules, InvaGen Pharma, Tentative Approval | Ramipril Capsules, Lupin Pharmaceuticals, Inc., Tentative Approval | Ramipril Capsules, Lupin Pharmaceuticals, Inc., Approval | Ramipril Capsules, Actavis Mid Atlantic, LLC, Approval | Ramipril Capsules, Sandoz Inc., Approval | Ramipril Capsules, Roxane Laboratories, Inc., Approval | Ramipril Capsules, Invagen Pharmaceuticals, Inc., Approval | Ramipril Capsules, Teva Pharmaceuticals USA, Approval | Ramipril Capsules, Dr. Reddy's Laboratories, Ltd., Approval | Agrylin (anagrelide hydrochloride) Capsules, Shire Development, Inc., Labeling Revision | Ramipril Capsules, Dr. Reddy's Labs, Ltd., Approval | Ramipril Capsules, Apotex Corp., Approval | Ramipril Capsules, Cipla Ltd, Approval | Ramipril Capsules, Zydus Pharmaceuticals USA Inc., Approval | Altace (ramipril) Capsules, King Pharmaceuticals, Inc., Labeling Revision | Altace (ramipril) Tablets, King Pharmaceuticals, Inc., Labeling Revision | Ramipril Capsules, Ranbaxy Laboratories Ltd., Approval | Altace (ramipril) Capsules, King Pharmaceuticals, Inc., Labeling Revision | Altace (ramipril) Tablets, King Pharmaceuticals, Inc., Labeling | Ramipril Tablets, Zydus Pharmaceuticals Inc., Approval Revision | Altace (ramipril) Tablets, King Pharmaceuticals, Inc., Labeling Revision | Altace (ramipril) Capsules, King Pharmaceuticals, Inc., Approval | Ramipril Capsules, Aurobindo Pharma, Ltd., Approval | Ramipril Tablets, Mylan Pharmaceuticals, Inc., Approval | Altace (ramipril) Tablets, King Pharmaceuticals, Inc., Labeling Revision | Altace (ramipril) Capsules, King Pharmaceuticals, Inc., Labeling Revision
  
|